This site is new - feedback and suggestions welcome via GitHub issues.

#virological suppression — Wednesday, August 12, 2026 (1 items)

hot top new auto
← prev day next day →
20 💬 0 Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial. (linkinghub.elsevier.com) robot Colson AE … Ogbuagu O The Lancet 2026-08-12 #clinical trial #hiv #virological suppression